Why Is RocketLab Stock Crashing, and is it a Buying Opportunity? | RKLB Stock Analysis

SUMMARY

Parkev Tatevosian, CFA, analyzes Rocket Lab's recent quarterly results, highlighting strong revenue growth and contract wins but noting the stock's sharp decline due to high valuation. He reiterates a hold rating, emphasizing that despite innovation and sector momentum, the current price remains above his fair value estimate.

MAIN POINTS

• Rocket Lab's stock fell over 7% after reporting quarterly results, following a prior 3.25% drop during regular trading hours. [0:00]
• The company posted record revenues of $234 million, up 62% year-over-year, and improved its net loss to $49 million from $66 million. [1:00]
• Rocket Lab's backlog surged 137% year-over-year to $2.36 billion, with over $1 billion in new contracts booked in the third quarter. [2:01]
• The company secured a $397 million contract with the US Space Force and continues to benefit from increased investor interest in space stocks post-SpaceX IPO. [3:02]
• Despite being up 15% year-to-date, Rocket Lab's share price has been volatile, peaking above $150 before falling to around $80, still above the analyst's $22 fair value estimate. [4:01]
• Rocket Lab trades at a forward price-to-sales ratio of 36, with projected growth rates declining from 54% in 2026 to 32% in 2028, leading to a reiterated hold rating. [6:02]

DETAILED ANALYSIS

Rocket Lab's recent quarterly financial report demonstrated significant operational progress, with revenues reaching a record $234 million, marking a 62% increase from the previous year and surpassing the prior quarter by $34 million. The company's net loss improved to $49 million, compared to $66 million a year earlier, indicating better cost management and operational efficiency. Despite these positive metrics, the stock experienced a sharp decline, attributed primarily to its elevated valuation prior to the earnings release.

This phenomenon is common among high-growth companies, where investor expectations are set so high that even strong results can trigger a sell-off if they do not exceed those expectations.

The company's business momentum is evident in its backlog, which surged 137% year-over-year to $2.36 billion. This backlog, representing future contracted revenue, reflects robust demand across Rocket Lab's launch and space systems divisions. Notably, over $1 billion in new contracts were booked in the third quarter alone, including a $397 million agreement with the US Space Force for advanced satellite delivery.

Such government contracts underscore Rocket Lab's growing credibility and strategic importance in the space technology sector.

Despite these achievements, Rocket Lab's valuation remains a concern. The shares trade at a forward price-to-sales ratio of 36, significantly higher than the S&P 500 average and even above its own 2025 levels. Analyst projections indicate decelerating growth, with revenue expected to rise by 54% in the current year, then taper to 39% in 2027 and 32% in 2028.

These growth rates, while strong, do not justify the current premium valuation. The analyst's discounted cash flow model estimates fair value at $22 per share, well below the current market price of around $80. While Rocket Lab is positioned as a leading innovator and an attractive alternative to SpaceX, its stock remains expensive relative to its fundamentals, leading to a continued hold recommendation.

LINKS

• YouTube channel membership for exclusive perks and spreadsheets.
• Motley Fool special offer for stock picks.
• Parkev Tatevosian's book on stock evaluation frameworks.
• Fiscal.ai investment research platform with viewer discount.
• Webull investing platform sign-up with bonus shares.
• Substack newsletter subscription for monthly updates.

KEYWORDS